从ESTP病理学2.0工作组考虑的要点:关于支持药物发现和开发的空间Omics技术的概述
Kerstin Hahn1, Bettina Amberg1,2, Josep M Monné Rodriguez1
1Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Toxicologic pathology
|February 11, 2025
概括
空间奥米克技术可以在组织中进行高维分子分析. 病理学家对于利用这些工具在毒理病理学和药物发现中对人类安全至关重要.
科学领域:
- 病理学 病理学 病理学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 生物分析和成像技术已经推进了组织样本分析.
- 空间奥米学允许在组织部分同时检测多个生物分子.
- 这使得能够在组织微解剖学上下文中进行高维分子分析,以探索疾病病理生理学.
研究的目的:
- 提高人们对新兴的空间奥米克技术及其在发现和毒理病理学中的应用的认识.
- 提供商业上可用的空间奥米克平台的概述,用于转录组,蛋白组和多原子组分析.
- 强调病理学家在利用空间信息学来进行翻译性药物发现和人类安全风险评估方面的作用.
主要方法:
- 审查常用的,商业上可用的空间奥米克平台.
- 讨论转录原子,蛋白质原子和多原子分析的技术方面.
- 在病理学和药物开发中的空间奥米克应用的说明性示例.
主要成果:
- 空间奥米克为复杂疾病病理生理学的精确,多维探索提供了一个强大的机会.
- 该综述涵盖了各种平台及其在理解组织环境中的分子变化的应用.
- 病理学家在整个空间学工作流程中发挥着至关重要的作用.
结论:
- 空间奥米克技术在目标发现,选,临床前评估和临床开发方面提供了新的机会.
- 空间奥米克的有效利用需要病理学家从假设到解释的参与.
- 这些技术将对化合物开发和安全评估产生重大影响.
更多相关视频
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
DNA Microarrays
17.2K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
17.2K
Genomics
35.7K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.7K
Structure-Activity Relationships and Drug Design
491
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
491
Proteomics
7.2K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.2K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K


